# US 2019/0316179 A1 · Fully automated nucleic acid extraction methods for tissue samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316179 A1
- Document ID: US20190316179A1
- Status: Published application
- Kind: A1
- Application number: 16/442,395
- Filed: 2019-06-14
- Published: 2019-10-17
- Earliest claimed: 2016-12-22
- Assignees: Ventana Medical Systems, Inc.
- Applicants: Ventana Medical Systems, Inc.
- Inventors: William Day; Megan C. Peccarelli
- Web page: https://patentgrep.com/patent/US20190316179A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Automated methods for extracting nucleic acid from one or more tissue samples disposed on slides are disclosed. The methods utilize an automated slide staining apparatus that dispenses a plurality of nucleic acid extraction reagents onto the tissue sample, thus creating an extracted nucleic acid sample. The extracted nucleic acid sample may be used directly in downstream applications such as nucleic acid amplification or sequencing procedures, or may be further purified.

## Claims

### Claim 1

An automated method for extracting nucleic acid from tissue samples disposed on one or more slides in an automated staining machine, said method comprising:
treating the samples on the one or more slides with a deparaffinization reagent;
treating the samples on the one or more slides with an antigen retrieval buffer;
treating the samples on the one or more slides with a protease buffer; and
heating the samples on the one or more slides to yield an eluate, wherein the eluate comprises isolated nucleic acid from the respective sample.

### Claim 2 (depends on 1)

The method of claim 1 further comprising removing the eluate from the samples on the one or more slides.

### Claim 3 (depends on 2)

The method of claim 2 further comprising purifying the isolated nucleic acid.

### Claim 4 (depends on 2)

The method of claim 2 further comprising performing nucleic acid amplification on the isolated nucleic acid.

### Claim 5 (depends on 3)

The method of claim 3 further comprising analyzing the isolated nucleic acid.

### Claim 6 (depends on 5)

The method of claim 5, wherein the analyzing comprises sequencing.

### Claim 7 (depends on 1)

The method of claim 1, wherein the nucleic acid is DNA.

### Claim 8 (depends on 1)

The method of claim 1 further comprising treating the samples on the one or more slides with guanidine thiocyanate after the samples on the one or more slides are treated with the protease.

### Claim 9 (depends on 8)

The method of claim 8, wherein the nucleic acid is RNA.

### Claim 10 (depends on 1)

The method of claim 1, wherein the samples on the one or more slides are FFPE samples, fresh samples, or frozen samples.

### Claim 11 (depends on 1)

The method of claim 1, wherein the samples are microdissected samples.

### Claim 12 (depends on 1)

The method of claim 1, wherein the samples on the one or more slides are unstained samples.

### Claim 13 (depends on 1)

The method of claim 1, wherein the samples on the one or more slides are stained samples.

### Claim 14 (depends on 12)

The method of claim 12, wherein the stained samples are samples stained with haematoxylin and eosin (H&E) or an immunohistochemistry dye or an in situ hybridization dye.

### Claim 15 (depends on 1)

The method of claim 1, wherein the automated staining machine comprises one or more dispensers for dispensing the deparaffinization reagent, antigen retrieval buffer, and protease onto the samples on the one or more slides.

### Claim 16 (depends on 15)

The method of claim 15, wherein the automated staining machine further comprises a heating element for heating the samples on the one or more slides.

### Claim 17

An automated method for extracting RNA from tissue samples disposed on one or more slides in an automated staining machine, said method comprising:
treating the samples on the one or more slides with a deparaffinization reagent;
treating the samples on the one or more slides with an antigen retrieval buffer;
treating the samples on the one or more slides with a protease;
treating the samples on the one or more slides with guanidine thiocyanate; and
heating the samples on the one or more slides to yield an eluate, wherein the eluate comprises isolated nucleic acid from the respective sample.

### Claim 18 (depends on 17)

The method of claim 17 further comprising removing the eluate from the samples on the one or more slides.

### Claim 19 (depends on 18)

The method of claim 18 further comprising purifying the isolated nucleic acid.

### Claim 20 (depends on 19)

The method of claim 19 further comprising performing nucleic acid amplification on the isolated nucleic acid.

### Claim 21 (depends on 21)

The method of claim 21 further comprising analyzing the isolated nucleic acid.

### Claim 22 (depends on 21)

The method of claim 21, wherein the analyzing comprises sequencing.

### Claim 23 (depends on 17)

The method of claim 17, wherein the samples on the one or more slides are FFPE samples, fresh samples, or frozen samples.

### Claim 24 (depends on 17)

The method of claim 17, wherein the samples are microdissected samples.

### Claim 25 (depends on 17)

The method of claim 17, wherein the samples on the one or more slides are unstained samples.

### Claim 26 (depends on 17)

The method of claim 17, wherein the samples on the one or more slides are stained samples.

### Claim 27 (depends on 26)

The method of claim 26, wherein the stained samples are samples stained with H&E or an immunohistochemistry dye or an in situ hybridization dye.

### Claim 28

An automated method for extracting nucleic acid from tissue samples disposed on one or more slides, said method comprising:
receiving the one or more slides comprising one or more tissue samples in an automated slide staining apparatus, wherein the automated slide staining apparatus is configured to automatically dispense a plurality of nucleic acid extraction reagents to the one or more tissue samples to treat the one or more tissue samples, respectively, the nucleic acid extraction reagents comprising a deparaffinization buffer, an antigen retrieval buffer, and a protease buffer;
dispensing said reagents in a predetermined sequence such that said reagents come into contact with the one or more tissue samples on the one or more slides;
treating the one or more samples with said reagents, thereby resulting in one or more extracted nucleic acid samples comprising extracted nucleic acid.

### Claim 29 (depends on 28)

The method of claim 28 further comprising heating the tissue samples to elute extracted nucleic acid from the tissue sample.

### Claim 30 (depends on 28)

The method of claim 28, further comprising removing the one or more extracted nucleic samples from the one or more slides.

### Claim 31 (depends on 30)

The method of claim 30, further comprising purifying the nucleic acid from one or more extracted nucleic acid samples.

### Claim 32 (depends on 31)

The method of claim 31, further comprising analyzing the nucleic acid from one or more extracted nucleic acid samples.

### Claim 33 (depends on 32)

The method of claim 32, wherein the analyzing comprises performing nucleic acid amplification.

### Claim 34 (depends on 32)

The method of claim 32, wherein the analyzing comprises nucleic acid sequencing.

### Claim 35 (depends on 28)

The method of claim 28, wherein the extracted nucleic acid is DNA.

### Claim 36 (depends on 28)

The method of claim 28, wherein the reagents further comprise guanidine thiocyanate.

### Claim 37 (depends on 36)

The method of claim 36, wherein the extracted nucleic acid is RNA.

### Claim 38 (depends on 28)

The method of claim 28, wherein the one or more tissue samples are fresh, frozen, formalin fixed or paraffin embedded.

### Claim 39 (depends on 28)

The method of claim 28, wherein the one or more tissue samples are stained.

### Claim 40

A method for isolating nucleic acid from a sample on a slide, said method comprising:
placing the sample on the slide on an automated staining machine;
running an extraction protocol on the automated staining machine, the extraction protocol instructs the automated staining machine to dispense reagents, the reagents comprising a deparaffinization buffer, an antigen retrieval buffer, and a protease buffer, the reagents are dispensed in a predetermined sequence such that said reagents come into contact with the sample on the slide thereby resulting in an eluate on the sample on the slide, the eluate comprising an isolated nucleic acid sample comprising isolated nucleic acid.

### Claim 41 (depends on 40)

The method of claim 40 further comprising heating the sample to yield the eulate on the sample on the slide.

### Claim 42 (depends on 40)

The method of claim 40 further comprising removing the eluate on the sample on the slide.

### Claim 43 (depends on 42)

The method of claim 42 further comprising purifying the isolated nucleic acid.

### Claim 44 (depends on 43)

The method of claim 43 further comprising performing nucleic acid amplification on the isolated nucleic acid.

### Claim 45 (depends on 43)

The method of claim 43 further comprising analyzing the isolated nucleic acid.

### Claim 46 (depends on 45)

The method of claim 45, wherein the analyzing comprises sequencing.

### Claim 47 (depends on 40)

The method of claim 40, wherein the nucleic acid is DNA or RNA.

### Claim 48 (depends on 40)

The method of claim 40, wherein the reagents further comprise guanidine thiocyanate.

### Claim 49 (depends on 40)

The method of claim 40, wherein the samples are FFPE samples, fresh samples, or frozen samples.

### Claim 50 (depends on 40)

The method of claim 40, wherein the samples are unstained samples.

### Claim 51 (depends on 40)

The method of claim 40, wherein the samples are stained samples.

### Claim 52 (depends on 52)

The method of claim 52, wherein the stained samples are samples stained with H&E or an immunohistochemistry dye or an in situ hybridization dye.

### Claim 53

A method for isolating nucleic acid from a sample on a slide, said method comprising:
placing the sample on the slide on a dissection instrument;
dissecting the sample on the slide to remove unwanted tissue;
placing the sample on the slide on an automated staining machine;
running an extraction protocol on the automated staining machine, the extraction protocol instructs the automated staining machine to dispense reagents, the reagents comprising a deparaffinization buffer, an antigen retrieval buffer, and a protease buffer, the reagents are dispensed in a predetermined sequence such that said reagents come into contact with the sample on the slide thereby resulting in an eluate on the sample on the slide, the eluate comprising an isolated nucleic acid sample comprising isolated nucleic acid.

### Claim 54 (depends on 53)

The method of claim 53 further comprising heating the sample to yield the eulate on the sample on the slide.

### Claim 55 (depends on 53)

The method of claim 53 further comprising removing the eluate on the sample on the slide.

### Claim 56 (depends on 55)

The method of claim 55 further comprising purifying the isolated nucleic acid.

### Claim 57 (depends on 56)

The method of claim 56 further comprising performing nucleic acid amplification on the isolated nucleic acid.

### Claim 58 (depends on 57)

The method of claim 57 further comprising analyzing the isolated nucleic acid.

### Claim 59 (depends on 58)

The method of claim 58, wherein the analyzing comprises sequencing.

### Claim 60 (depends on 53)

The method of claim 53, wherein the nucleic acid is DNA or RNA.

### Claim 61 (depends on 53)

The method of claim 53, wherein the reagents include guanidine thiocyanate.

### Claim 62 (depends on 53)

The method of claim 53, wherein the samples are FFPE samples, fresh samples, or frozen samples.

### Claim 63 (depends on 53)

The method of claim 53, wherein the samples are unstained samples.

### Claim 64 (depends on 53)

The method of claim 53, wherein the samples are stained samples.

### Claim 65 (depends on 64)

The method of claim 64, wherein the stained samples are samples stained with H&E or an immunohistochemistry dye or an in situ hybridization dye.

### Claim 66 (depends on 1)

An automated staining machine for performing a method according claim 1.

### Claim 67 (depends on 1)

An automated staining machine comprising a memory coupled to a processor, wherein the memory stores computer-readable instructions that, when executed by the processor, cause the automated staining machine to perform operations for a method according to claim 1.

### Claim 68 (depends on 1)

An automated system comprising a slide holder, reagents, and dispensers for performing a method according to claim 1.

### Claim 69 (depends on 1, 68)

The system of claim 68 further comprising a memory coupled to a processor, wherein the memory stores computer-readable instructions that, when executed by the processor, cause the automated system to perform operations for a method according to claim 1.

### Claim 70 (depends on 68)

The system of claim 68, wherein the dispensers are adapted to dispense reagents onto a slide in the slide holder.

### Claim 71 (depends on 1)

A workflow method comprising: preparing a tissue section from a tissue of a patient on a slide; applying method according to claim 1 to the tissue section, wherein the method is for extracting nucleic acid.

### Claim 72 (depends on 57)

The workflow method of claim 57, wherein the tissue of the patient is a tumor tissue.

### Claim 73 (depends on 1)

A workflow method comprising:
sectioning a formalin-fixed paraffin-embedded (FFPE) tissue section from a tumor of a patient;
mounting the tissue section on a slide;
applying a method according to claim 1 to the tissue section in an automated machine that automatically dispenses a plurality of nucleic acid extraction reagents to the tissue section, resulting in an extracted nucleic acid sample comprising extracted nucleic acid derived from the tissue section.

### Claim 74 (depends on 1)

An automated system for purifying nucleic acid, said system comprising: an automated machine for accepting samples, wherein the automated machine executes a method according to claim 1, wherein the method purifies nucleic acid.

### Claim 75 (depends on 1)

An automated system for analyzing nucleic acid, said system comprising an automated machine for accepting samples, wherein the automated machine executes a method according to claim 1, wherein the method purifies nucleic acid; wherein the automated machine further executes a method for analyzing the purified nucleic acid.

### Claim 76 (depends on 68)

The system of claim 68, wherein the method for analyzing the nucleic acid comprises amplifying the nucleic acid.

### Claim 77 (depends on 68)

The system of claim 68, wherein the method for analyzing the nucleic acid comprises sequencing the nucleic acid.

### Claim 78 (depends on 1)

An automated system for amplifying nucleic acid, said system comprising: an automated machine for accepting samples, wherein the automated machine executes a method according to claim 1, wherein the method purifies nucleic acid; wherein the automated machine further executes a method for amplifying the purified nucleic acid.

### Claim 79 (depends on 1)

An automated system for sequencing nucleic acid, said system comprising: an automated machine for accepting samples, wherein the automated machine executes a method according to claim 1, wherein the method purifies nucleic acid; wherein the automated machine further executes a method for sequencing the purified nucleic acid.

### Claim 80 (depends on 1)

A kit comprising nucleic acid extraction reagents for use on an automated staining machine according to claim 1.

### Claim 81 (depends on 80)

The kit of claim 80 comprising two or more of: a deparaffinization buffer, a protease reagent and an antigen retrieval buffer.

### Claim 82 (depends on 80)

The kit of claim 80 further comprising guanidine thiocyanate.
